Stigmatization of Chinese and Asian-looking people during the COVID-19 pandemic in Germany.

Avoidance COVID-19 Coronavirus Disease Pandemic Pathogen SARS-CoV-2 Stigma Stigmatization Threat

Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
02 07 2021
Historique:
received: 23 09 2020
accepted: 11 06 2021
entrez: 3 7 2021
pubmed: 4 7 2021
medline: 9 7 2021
Statut: epublish

Résumé

The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic. As part of the "EUCLID" project ( https://euclid.dbvis.de ), a total of 5011 persons from Germany were surveyed via an online-questionnaire between February 2 There was no evidence for an increase in the stigmatization of Chinese and Asian-looking people across three topics, that is personal proximity, air travel, and medical measures upon arrival from China. The present findings provide good news in that participants showed an adaptive response to the infectious disease threat rather than displaying increased stigmatization. Further research is necessary to specify the conditions that increase the risk of stigmatization in response to infectious disease threats.

Sections du résumé

BACKGROUND
The outbreak and global spread of COVID-19 was accompanied by an increase in reports of stigmatization of Chinese and Asian-looking people. The behavioral immune system provides a framework for stigmatization in response to infectious disease threats. Specifically, stigmatization might increase with rising levels of infectious disease threat. The present study aimed to examine this hypothesis during the early phase of the COVID-19 pandemic.
METHODS
As part of the "EUCLID" project ( https://euclid.dbvis.de ), a total of 5011 persons from Germany were surveyed via an online-questionnaire between February 2
RESULTS
There was no evidence for an increase in the stigmatization of Chinese and Asian-looking people across three topics, that is personal proximity, air travel, and medical measures upon arrival from China.
CONCLUSIONS
The present findings provide good news in that participants showed an adaptive response to the infectious disease threat rather than displaying increased stigmatization. Further research is necessary to specify the conditions that increase the risk of stigmatization in response to infectious disease threats.

Identifiants

pubmed: 34215224
doi: 10.1186/s12889-021-11270-1
pii: 10.1186/s12889-021-11270-1
pmc: PMC8253234
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1296

Subventions

Organisme : Bundesministerium für Bildung und Forschung
ID : BMBF for 01EL1820A SMARTACT
Organisme : Bundesministerium für Bildung und Forschung
ID : BMBF for 01EL1820A SMARTACT
Organisme : Deutsche Forschungsgemeinschaft
ID : DFG FOR 2374 RiskDynamics
Organisme : Deutsche Forschungsgemeinschaft
ID : DFG FOR 2374 RiskDynamics
Organisme : Centre for the Advanced Study of Collective Behaviour
ID : EXC 2117 - 422037984 Collective Behaviour
Organisme : Centre for the Advanced Study of Collective Behaviour
ID : EXC 2117 - 422037984 Collective Behaviour

Références

J Soc Psychol. 2013 Mar-Apr;153(2):212-28
pubmed: 23484348
Psychol Bull. 2001 Mar;127(2):187-208
pubmed: 11316010
Aust N Z J Psychiatry. 2009 Mar;43(3):183-200
pubmed: 19221907
World J Clin Cases. 2020 Feb 26;8(4):652-657
pubmed: 32149049
Ethn Health. 2021 Jan;26(1):110-125
pubmed: 33307773
Evol Psychol Sci. 2021 Apr 22;:1-11
pubmed: 33903849
Pers Individ Dif. 2020 Dec 1;167:110221
pubmed: 32834281
J Transcult Nurs. 2020 Jul;31(4):326-332
pubmed: 32316872
J Med Internet Res. 2020 May 6;22(5):e19301
pubmed: 32343669
Soc Sci Med. 1997 Sep;45(6):903-14
pubmed: 9255923
Am J Trop Med Hyg. 2020 Jun;102(6):1158-1159
pubmed: 32314701
Annu Rev Psychol. 2005;56:393-421
pubmed: 15709941
J Med Internet Res. 2020 Nov 16;22(11):e22639
pubmed: 33156807
Psychol Sci. 2016 Jul;27(7):935-44
pubmed: 27207872
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Front Psychol. 2019 Oct 25;10:2412
pubmed: 31708846
Evol Psychol. 2019 Jan-Mar;17(1):1474704919826851
pubmed: 30739486
Lancet. 2020 Apr 11;395(10231):1194
pubmed: 32246915
Lancet. 2020 Apr 18;395(10232):1250-1251
pubmed: 32224298
Lancet Infect Dis. 2020 May;20(5):533-534
pubmed: 32087114
Ethn Health. 2021 Jan;26(1):94-109
pubmed: 33059486
Philos Trans R Soc Lond B Biol Sci. 2011 Dec 12;366(1583):3433-52
pubmed: 22042920
Asian J Criminol. 2021 Jan 6;:1-24
pubmed: 33425062
Evol Psychol Sci. 2020 Aug 13;:1-18
pubmed: 32837865

Auteurs

Julia E Koller (JE)

University of Konstanz, 78457, Konstanz, Germany.

Karoline Villinger (K)

University of Konstanz, 78457, Konstanz, Germany.

Nadine C Lages (NC)

University of Konstanz, 78457, Konstanz, Germany.

Isabel Brünecke (I)

University of Konstanz, 78457, Konstanz, Germany.

Joke M Debbeler (JM)

University of Konstanz, 78457, Konstanz, Germany.

Kai D Engel (KD)

University of Konstanz, 78457, Konstanz, Germany.

Sofia Grieble (S)

University of Konstanz, 78457, Konstanz, Germany.

Peer C Homann (PC)

University of Konstanz, 78457, Konstanz, Germany.

Robin Kaufmann (R)

University of Konstanz, 78457, Konstanz, Germany.

Kim M Koppe (KM)

University of Konstanz, 78457, Konstanz, Germany.

Hannah Oppenheimer (H)

University of Konstanz, 78457, Konstanz, Germany.

Vanessa C Radtke (VC)

University of Konstanz, 78457, Konstanz, Germany.

Sarah Rogula (S)

University of Konstanz, 78457, Konstanz, Germany.

Johanna Stähler (J)

University of Konstanz, 78457, Konstanz, Germany.

Britta Renner (B)

University of Konstanz, 78457, Konstanz, Germany.

Harald T Schupp (HT)

University of Konstanz, 78457, Konstanz, Germany. harald.schupp@uni-konstanz.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH